These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1583174)
1. Distribution patterns and frequency of proliferating cells in cutaneous keratinocytic neoplasms. Immunohistochemical study with a monoclonal antibody (TOB7) used against proliferating cell nuclear antigen. Saida T; Dohi S; Sadaki M; Tokuda Y; Ikegawa S; Takasaki Y J Am Acad Dermatol; 1992 May; 26(5 Pt 1):744-8. PubMed ID: 1583174 [TBL] [Abstract][Full Text] [Related]
2. Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. Bowen AR; Hanks AN; Murphy KJ; Florell SR; Grossman D Am J Dermatopathol; 2004 Jun; 26(3):177-81. PubMed ID: 15166502 [TBL] [Abstract][Full Text] [Related]
3. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Takahashi H; Strutton GM; Parsons PG Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189 [TBL] [Abstract][Full Text] [Related]
4. Expression of proliferation-associated proteins (proliferating cell nuclear antigen and Ki-67 antigen) in Bowen's disease. Baum HP; Meurer I; Unteregger G Br J Dermatol; 1994 Aug; 131(2):231-6. PubMed ID: 7917988 [TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma. Phillips P; Helm KF J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions]. Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557 [TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. An immunohistochemical study of proliferating cell populations. Geary WA; Cooper PH J Cutan Pathol; 1992 Dec; 19(6):458-68. PubMed ID: 1362576 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody JC1: new reagent for studying cell proliferation. Garrido MC; Cordell JL; Becker MH; Key G; Gerdes J; Jones M; Gatter KC; Mason DY J Clin Pathol; 1992 Oct; 45(10):860-5. PubMed ID: 1430255 [TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical identification of proliferative hepatocytes using monoclonal antibody to proliferating cell nuclear antigen (PCNA/cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha. Kawakita N; Seki S; Yanai A; Sakaguchi H; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S14-20. PubMed ID: 1374217 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833 [TBL] [Abstract][Full Text] [Related]
11. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Yu CC; Filipe MI Histochem J; 1993 Dec; 25(12):843-53. PubMed ID: 7906685 [TBL] [Abstract][Full Text] [Related]
12. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840 [TBL] [Abstract][Full Text] [Related]
13. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774 [TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen (PCNA/cyclin) in plant proliferating cells: immunohistochemical and quantitative analysis using autoantibody and murine monoclonal antibodies to PCNA. Daidoji H; Takasaki Y; Nakane PK Cell Biochem Funct; 1992 Jun; 10(2):123-32. PubMed ID: 1352740 [TBL] [Abstract][Full Text] [Related]
15. A sandwich type enzyme-linked immunosorbent assay for proliferating cell nuclear antigen (PCNA)/cyclin using monoclonal antibodies. Takasaki Y; Ohgaki M; Kodama A; Ogata K; Hashimoto H; Shirai T; Hirose S J Immunol Methods; 1990 Sep; 132(2):227-37. PubMed ID: 1698875 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in endometrial carcinoma with argyrophil cells. Ueda G; Sawada M; Ogawa H; Tanizawa O; Tsujimoto M Gynecol Oncol; 1993 Mar; 48(3):314-6. PubMed ID: 8096489 [TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen distribution in verrucous carcinoma of the skin. Noel JC; Heenen M; Peny MO; Fayt I; Peny J; De Dobbeleer G; Haot J; Galand P Br J Dermatol; 1995 Dec; 133(6):868-73. PubMed ID: 8547037 [TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Siitonen SM; Kallioniemi OP; Isola JJ Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759 [TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
20. Age-related proliferative activity in dermal melanocytic naevi detected by PCNA/cyclin expression. Tu P; Miyauchi S; Miki Y Br J Dermatol; 1993 Jul; 129(1):65-8. PubMed ID: 8103667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]